Register Login

C4 Therapeutics Inc (CCCC)

(90% Positive) C4 Therapeutics Inc (CCCC) Announces Enrollment Update for Initiate Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 7:03 p.m.

    📋 C4 Therapeutics Inc (CCCC) - Clinical Trial Update

    Filing Date: 2026-01-14

    Accepted: 2026-01-14 07:12:35

    Event Type: Clinical Trial Update

    Event Details:

    C4 Therapeutics Inc (CCCC) Announces Clinical Trial Update C4 Therapeutics Inc (CCCC) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: Initiate, trials
    • Clinical Stage: Phase 2
    • Collaboration: C4 Therapeutics, Inc.
    • Updated Timeline: Q2 2026, Q1 2026

    🔬 Clinical Development Pipeline (C4 Therapeutics Inc):

    Product Type Development Stage Therapeutic Area Source
    ATI-1123 (active drug = docetaxel) DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Elranatamab BIOLOGICAL Phase PHASE1 Multiple Myeloma (MM) ClinicalTrials.gov
    Auxiliary Medicinal Product - Luteinizing hormone-releasing hormone (LHRH) analogues DRUG Phase PHASE3 Advanced Breast Cancer ClinicalTrials.gov
    Placebo control / saline vehicle OTHER Phase PHASE3 Knee Osteoarthritis ClinicalTrials.gov
    targeted fusion protein therapy PROCEDURE Phase PHASE1 Malignant Glioma ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Delayed Treatment with Brelovitug 300mg DRUG Phase PHASE3 Chronic Hepatitis D Infection ClinicalTrials.gov
    Cemsidomide DRUG Phase PHASE1 Multiple Myeloma (MM) ClinicalTrials.gov
    Venetoclax DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Azacitidine DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Tagraxofusp DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    THRV-1268 DRUG Phase PHASE2 Long QT Syndrome (LQTS) 2 ClinicalTrials.gov
    baseline lead-in OTHER Phase PHASE2 Long QT Syndrome (LQTS) 2 ClinicalTrials.gov
    IMSB301 DRUG Phase PHASE1 Type 1 Interferonopathies ClinicalTrials.gov
    Tamoxifen DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Exemestane DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Letrozole DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Anastrozole DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Elacestrant DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    FOLFOX DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Ribociclib DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Fulvestrant DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Trastuzumab DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    BBO-10203 DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI) DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    BOLD-100 +/- FOLFOX Chemotherapy (Arm VII) DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    BBO-8520 DRUG Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    MGB 600 mg + ALT-B4 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MGB 600 mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MGB 400 mg + ALT-B4 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MGB 200 mg + ALT-B4 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MGB 400 mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MGB 200 mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE2 Estrogen-receptor-positive Breast Cancer ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 CKD ClinicalTrials.gov
    Veverimer DRUG Phase PHASE3 CKD ClinicalTrials.gov
    NTX-1472 DRUG Phase PHASE2 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    NALIRIFOX DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Cetuximab DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Platinum chemotherapy (cisplatin or carboplatin) DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    BBO-11818 DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    ABX-002 DRUG Phase PHASE2 Bipolar Disorder Depression ClinicalTrials.gov
    GLB-001 DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Tislelizumab DRUG Phase PHASE1 Advanced Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Arsenic Trioxide (ATO) DRUG Phase PHASE1 Advanced Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    ATRA DRUG Phase PHASE1 Advanced Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    enzalutamide DRUG Phase PHASE1 Prostate Adenocarcinoma ClinicalTrials.gov
    The SEAL™ Saccular Endovascular Aneurysm Lattice System DEVICE Phase PHASE3 Intracranial Aneurysm ClinicalTrials.gov
    PEF ablation DEVICE Preclinical Soft Tissue Lesion ClinicalTrials.gov
    GAL-101 DRUG Phase PHASE2 Geographic Atrophy of the Macula ClinicalTrials.gov
    KTX-2001 + Darolutamide (NUBEQA®) DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    KTX-2001 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    MEN2312 DRUG Phase PHASE1 Advanced Breast Cancer ClinicalTrials.gov
    CUSP06 DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Encaleret DRUG Phase PHASE2 Autosomal Dominant Hypocalcemia Type 1 (ADH1) ClinicalTrials.gov
    ENX-205 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    normal saline DRUG Phase PHASE2 Acute Respiratory Distress Syndrome ClinicalTrials.gov
    Rhu-pGSN DRUG Phase PHASE2 Acute Respiratory Distress Syndrome ClinicalTrials.gov
    Capivasertib DRUG Phase PHASE1 Melanoma (Skin Cancer) ClinicalTrials.gov
    DFMO DRUG Phase PHASE1 Melanoma (Skin Cancer) ClinicalTrials.gov
    AMXT 1501 Dicaprate DRUG Phase PHASE1 Melanoma (Skin Cancer) ClinicalTrials.gov
    Combination Agent DRUG Phase PHASE1 Solid Tumor Cancer ClinicalTrials.gov
    AVZO-103 DRUG Phase PHASE1 Solid Tumor Cancer ClinicalTrials.gov
    RSC-1255 Dose Expansion DRUG Phase PHASE1 Advanced Malignant Solid Neoplasm ClinicalTrials.gov
    RSC-1255 Dose Escalation DRUG Phase PHASE1 Advanced Malignant Solid Neoplasm ClinicalTrials.gov
    SM04690 DRUG Phase PHASE2 Knee Osteoarthritis ClinicalTrials.gov
    VENT-03 DRUG Phase PHASE2 Cutaneous Lupus Erythematosus (CLE) ClinicalTrials.gov
    EG-101 DRUG Phase PHASE1 Pre-eclampsia ClinicalTrials.gov
    TTX-080 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    FOLFIRI DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    AVZO-023 DRUG Phase PHASE1 HR+/HER2- Breast Cancer ClinicalTrials.gov
    AVZO-021 DRUG Phase PHASE1 HR+/HER2- Breast Cancer ClinicalTrials.gov
    ABF-101 DRUG Phase PHASE1 Age Related Macular Degeneration (ARMD) ClinicalTrials.gov
    Bulevirtide 2 mg and Brelovitug - 300 mg DRUG Phase PHASE3 Chronic Hepatitis D Infection ClinicalTrials.gov
    Brelovitug 300 mg DRUG Phase PHASE3 Chronic Hepatitis D Infection ClinicalTrials.gov
    ENX-104 DRUG Phase PHASE1 Major Depressive Disorder ClinicalTrials.gov
    ZE46-0134 DRUG Phase PHASE1 AML With Gene Mutations ClinicalTrials.gov
    ELK-003 (Standarized Amniotic Fluid Secretome Eye Drops) BIOLOGICAL Phase PHASE1 Junctional Epidermolysis Bullosa ClinicalTrials.gov
    75 mg Usnoflast DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov
    50 mg Usnoflast DRUG Phase PHASE2 Amyotrophic Lateral Sclerosis (ALS) ClinicalTrials.gov
    Relizorb Enzyme Cartridge DEVICE Preclinical Short Bowel Syndrome ClinicalTrials.gov
    Placebo Comparator DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    ENA-001 DRUG Phase PHASE1 Respiratory Depression ClinicalTrials.gov
    all-trans retinoic acid (ATRA) DRUG Phase PHASE3 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    IV Arsenic Trioxide DRUG Phase PHASE3 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    Oral ATO DRUG Phase PHASE3 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    Sham Digital Therapeutic DEVICE Approved Insomnia ClinicalTrials.gov
    BELL-001 Digital Therapeutic DEVICE Approved Insomnia ClinicalTrials.gov
    Brelovitug 900 mg DRUG Phase PHASE3 Chronic Hepatitis D Infection ClinicalTrials.gov
    IAM1363 DRUG Phase PHASE1 HER2 Mutation-Related Tumors ClinicalTrials.gov
    Placebo-to-match SION-719 DRUG Phase PHASE2 Cystic Fibrosis (CF) ClinicalTrials.gov
    SION-719 DRUG Phase PHASE2 Cystic Fibrosis (CF) ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE1 Small-cell Lung Cancer ClinicalTrials.gov
    Cirtuvivint DRUG Phase PHASE1 Small-cell Lung Cancer ClinicalTrials.gov
    Mobile Auditory Rehabilitation DEVICE Approved Cochlear Implant ClinicalTrials.gov
    Semaglutide 1 mg DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    HT-6184 Matching Placebo DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    HT-6184 DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    T-cell Receptor-engineered T-cells BIOLOGICAL Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Positron Emission Tomography PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Multigated Acquisition Scan PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Magnetic Resonance Imaging PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Leukapheresis PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Echocardiography PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Computed Tomography PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Biopsy PROCEDURE Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Bendamustine DRUG Phase PHASE1 Metastatic Malignant Solid Neoplasm ClinicalTrials.gov
    Interleukin-2 DRUG Phase PHASE1 Select Advanced Solid Tumors ClinicalTrials.gov
    KSQ-004EX DRUG Phase PHASE1 Select Advanced Solid Tumors ClinicalTrials.gov
    EG-501 DRUG Phase PHASE2 Neuropsychiatric Systemic Lupus Erythematosus ClinicalTrials.gov
    VLS-01-BU Placebo DRUG Phase PHASE2 Treatment Resistant Depression ClinicalTrials.gov
    VLS-01-203 BU DRUG Phase PHASE2 Treatment Resistant Depression ClinicalTrials.gov
    Zelpultide alfa DRUG Phase PHASE2 Bronchopulmonary Dysplasia ClinicalTrials.gov
    Air-sham OTHER Phase PHASE2 Bronchopulmonary Dysplasia ClinicalTrials.gov
    Pembrolizumab - anti-PD-1 antibody BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Itraconazole (200 mg) DRUG Phase PHASE1 AML ClinicalTrials.gov
    Rabeprazole, 20mg oral DRUG Phase PHASE1 AML ClinicalTrials.gov
    ZE46-0134 or placebo DRUG Phase PHASE1 AML ClinicalTrials.gov
    ALTA3263 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Stage 2: Placebo DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 2: Naltrxone/Acetaminophen low dose DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 2: Naltrexone/Acetaminophen medium dose DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 2: Naltrxone/Acetaminophen high dose DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage1: Placebo DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 1: Acetaminophen DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 1: Naltrexone DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Stage 1: Naltrexone/Acetaminophen DRUG Phase PHASE2 Migraine ClinicalTrials.gov
    Lenvatinib Capsules DRUG Phase PHASE3 Advanced Endometrial Cancer ClinicalTrials.gov
    Pembrolizumab 100 mg/ 4 ml (25 mg/ml) Injection DRUG Phase PHASE3 Advanced Endometrial Cancer ClinicalTrials.gov
    EG-007 DRUG Phase PHASE3 Advanced Endometrial Cancer ClinicalTrials.gov
    VV-14295 GENETIC Phase PHASE1 Geographic Atrophy Secondary to Age-related Macular Degeneration ClinicalTrials.gov
    Pembrolizumab 100 mg/4 mL (25 mg/ml) Injection DRUG Phase PHASE2 Advanced Endometrial Cancer ClinicalTrials.gov
    EG-301 DRUG Phase PHASE2 Non-Exudative (Dry) Age-related Macular Degeneration (dAMD) ClinicalTrials.gov
    ARD-101 DRUG Phase PHASE3 Hyperphagia ClinicalTrials.gov
    CST-3056 DRUG Phase PHASE2 Neurogenic Orthostatic Hypotension ClinicalTrials.gov
    Combination Agent 2 DRUG Phase PHASE1 Solid Tumor Cancer ClinicalTrials.gov
    Combination Agent 1 DRUG Phase PHASE1 Solid Tumor Cancer ClinicalTrials.gov
    AVZO-1418 DRUG Phase PHASE1 Solid Tumor Cancer ClinicalTrials.gov
    Eflornithine (DFMO) DRUG Phase PHASE1 Atypical Teratoid/Rhabdoid Tumor ClinicalTrials.gov
    PTP-01 BIOLOGICAL Phase PHASE3 Knee Osteoarthritis ClinicalTrials.gov
    Positron Emission Tomography (PET)/Magnetic Resonance Imaging (MRI) PROCEDURE Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    Positron Emission Tomography (PET)/Computerized tomography (CT) PROCEDURE Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    YS5 antibody BIOLOGICAL Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    89Zr-DFO-YS5 DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    Rabeprazole 20 mg DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    ZE50-0134 or placebo DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Provides Sleep hygiene education text in application DEVICE Approved Insomnia ClinicalTrials.gov
    Provides meaningless sound in application DEVICE Approved Insomnia ClinicalTrials.gov
    Sleep inducing digital sound application DEVICE Approved Insomnia ClinicalTrials.gov
    ZE 50-0134 DRUG Phase PHASE1 CLL / SLL ClinicalTrials.gov
    IGT-303 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Auxiliary Medicinal Product - Dexamethasone DRUG Phase PHASE3 Advanced Breast Cancer ClinicalTrials.gov
    Everolimus DRUG Phase PHASE3 Advanced Breast Cancer ClinicalTrials.gov
    ECT204 T cells BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Olaparib DRUG Phase PHASE2 Hormone Receptor Positive HER-2 Negative Breast Cancer ClinicalTrials.gov
    Olaparib + Elacestrant DRUG Phase PHASE2 Hormone Receptor Positive HER-2 Negative Breast Cancer ClinicalTrials.gov
    1% Lidocaine HCL DRUG Phase PHASE2 Chronic Pain ClinicalTrials.gov
    ST-01 DRUG Phase PHASE2 Chronic Pain ClinicalTrials.gov
    ACDN-01 DRUG Phase PHASE1 Stargardt Disease ClinicalTrials.gov
    IMP1734 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Chemotherapy DRUG Phase PHASE3 Metastatic Pancreatic Cancer ClinicalTrials.gov
    GFH375 DRUG Phase PHASE3 Metastatic Pancreatic Cancer ClinicalTrials.gov
    Ofloxacin Eye Drops DRUG Phase PHASE2 Acute Bacterial Conjunctivitis ClinicalTrials.gov
    IVIEW-1201 DRUG Phase PHASE2 Acute Bacterial Conjunctivitis ClinicalTrials.gov
    MT-501 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    SL1002 DRUG Phase PHASE3 Osteoarthritis Knee Pain ClinicalTrials.gov
    ALTA2618 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    ATTO-1310 Placebo DRUG Phase PHASE1 Normal Volunteers ClinicalTrials.gov
    ATTO-1310 DRUG Phase PHASE1 Normal Volunteers ClinicalTrials.gov
    PVT201 DRUG Phase PHASE1 Primary Biliary Cholangitis (PBC) ClinicalTrials.gov
    IN-001 13.59 mg Sublingual Spray DRUG Phase PHASE1 Food Allergy ClinicalTrials.gov
    IN-001 9.06 mg Sublingual Spray DRUG Phase PHASE1 Food Allergy ClinicalTrials.gov
    Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle DRUG Phase PHASE1 Food Allergy ClinicalTrials.gov
    Epinephrine Auto-Injector 0.3 mg/0.3 mL DRUG Phase PHASE1 Food Allergy ClinicalTrials.gov
    EMP-01 Placebo DRUG Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    EMP-01 DRUG Phase PHASE2 Social Anxiety Disorder ClinicalTrials.gov
    Trametinib DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    CFT1946 DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    ENX-102 DRUG Phase PHASE2 Social Anxiety Disorder (SAD) ClinicalTrials.gov
    Avacincaptad DRUG Phase PHASE2 Geographic Atrophy of the Macula ClinicalTrials.gov
    AVD-104 DRUG Phase PHASE2 Geographic Atrophy of the Macula ClinicalTrials.gov
    ATTO-3712 DRUG Phase PHASE1 Normal Volunteers ClinicalTrials.gov
    STMC-103H BIOLOGICAL Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    APX-343A DRUG Phase PHASE1 Advanced Solid Cancer ClinicalTrials.gov
    IkT-148009 (risvodetinib) DRUG Phase PHASE2 Parkinson Disease ClinicalTrials.gov
    Sacituzumab Govitecan-hziy DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Abemaciclib DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Palbociclib DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Bone Marrow Aspiration PROCEDURE Phase PHASE1 Juvenile Myelomonocytic Leukemia ClinicalTrials.gov
    CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR BIOLOGICAL Phase PHASE1 Juvenile Myelomonocytic Leukemia ClinicalTrials.gov
    SKY-0515 Placebo DRUG Phase PHASE2 Huntington Disease ClinicalTrials.gov
    SKY-0515 DRUG Phase PHASE2 Huntington Disease ClinicalTrials.gov
    9-ING-41 DRUG Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Losartan DRUG Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    FOLFIRNINOX DRUG Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Treatment D: SDK001 (Arsenic Trioxide Oral solution) with calcium carbonate DRUG Phase PHASE1 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    Treatment C: SDK001 (Arsenic Trioxide Oral solution) under fed state DRUG Phase PHASE1 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    Treatment B: SDK001 (Arsenic Trioxide Oral solution) under faster state DRUG Phase PHASE1 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    Treatment A: Arsenic Trioxide (ATO) Intravenous DRUG Phase PHASE1 Acute Promyelocytic Leukemia (APL) ClinicalTrials.gov
    ALMB-0166 DRUG Phase PHASE1 Acute Spinal Cord Injury ClinicalTrials.gov
    copper histidinate DRUG Preclinical Menkes Disease ClinicalTrials.gov
    TSRA-196 DRUG Phase PHASE1 Alpha-1 Antitrypsin Deficiency (AATD) ClinicalTrials.gov
    Imitation Procedure PROCEDURE Phase PHASE1 AMN ClinicalTrials.gov
    SBT101 GENETIC Phase PHASE1 AMN ClinicalTrials.gov
    SL-401 DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Arm 2B: TRACT/MONO CNI BIOLOGICAL Phase PHASE2 Kidney Transplantation ClinicalTrials.gov
    Arm 2A: TRACT/MONO mTOR BIOLOGICAL Phase PHASE2 Kidney Transplantation ClinicalTrials.gov
    Arm 1: SOC (mTOR + CNI) DRUG Phase PHASE2 Kidney Transplantation ClinicalTrials.gov
    MT-201 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Daratumumab Hyaluronidase-fihj DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    TTI-622 DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    LLX-424 DRUG Phase PHASE2 Kidney Stones ClinicalTrials.gov
    1327 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    998 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    750 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    564 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    424 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    254 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    152 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    76 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    38 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    19 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    9.5 microCi of 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    4.7 microCi 225Ac-MTI-201 DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    NPT 2042 (Test formula/Formulation 2) DRUG Phase PHASE1 Epilepsy ClinicalTrials.gov
    NPT 2042 (Reference formula/Formulation 1) DRUG Phase PHASE1 Epilepsy ClinicalTrials.gov
    Natural History Observation OTHER Preclinical AMN ClinicalTrials.gov
    Infigratinib DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    VENT-02 DRUG Phase PHASE1 Parkinson Disease ClinicalTrials.gov
    Tagraxofusp (Cycles 3-12) DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Tagraxofusp (Cycles 1-2) DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Infigratinib 0.25 mg/kg DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib 0.128 mg/kg DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib 0.064 mg/kg DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib 0.032 mg/kg DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib 0.016 mg/kg DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    PULSAR RADIATION Phase PHASE2 Oligometastatic Disease ClinicalTrials.gov
    Immune checkpoint inhibitor DRUG Phase PHASE2 Oligometastatic Disease ClinicalTrials.gov
    IMSA101 DRUG Phase PHASE2 Oligometastatic Disease ClinicalTrials.gov
    Chia seeds OTHER Approved Stool Spore Colony Forming Units ClinicalTrials.gov
    HLD-0915 DRUG Phase PHASE1 Prostate Cancer Metastatic Disease ClinicalTrials.gov
    Digital Therapeutic DEVICE Phase PHASE3 Schizophrenia ClinicalTrials.gov
    Study App DEVICE Phase PHASE3 Schizophrenia ClinicalTrials.gov
    ACTM-838 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    NPT 2042 DRUG Phase PHASE2 Epilepsy, Generalized ClinicalTrials.gov
    Hyperbaric chamber OTHER Phase PHASE2 Decompression Sickness ClinicalTrials.gov
    Recombinant human plasma gelsolin post-exposure DRUG Phase PHASE2 Decompression Sickness ClinicalTrials.gov
    Recombinant human plasma gelsolin pre-exposure DRUG Phase PHASE2 Decompression Sickness ClinicalTrials.gov
    Sodium Chloride 0.9% Inj post-exposure DRUG Phase PHASE2 Decompression Sickness ClinicalTrials.gov
    Sodium Chloride 0.9% Inj pre-exposure DRUG Phase PHASE2 Decompression Sickness ClinicalTrials.gov
    BPT567 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Saroglitazar magnesium 1 mg DRUG Phase PHASE3 Primary Biliary Cholangitis ClinicalTrials.gov
    NATACYN® DRUG Phase PHASE2 Fungal Keratitis ClinicalTrials.gov
    Alpelisib DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    RELiZORB™ DEVICE Approved Multi Organ Failure ClinicalTrials.gov
    GFH276 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    ORKA-002 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Trastuzumab Deruxtecan DRUG Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    DT2216 DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Delafloxacin Powder DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Delafloxacin DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TTI-101 DRUG Phase PHASE1 Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    Hydrochlorothiazide DRUG Approved Hypertension ClinicalTrials.gov
    Nebivolol DRUG Approved Hypertension ClinicalTrials.gov
    ALTH12-2:4 DRUG Phase PHASE1 Ulcerative Colitis ClinicalTrials.gov
    ALTH12-1:4 DRUG Phase PHASE1 Ulcerative Colitis ClinicalTrials.gov
    mesalamine DRUG Phase PHASE1 Ulcerative Colitis ClinicalTrials.gov
    Mycophenolate mofetil (MMF) DRUG Phase PHASE1 End Stage Renal Disease ClinicalTrials.gov
    Tacrolimus DRUG Phase PHASE1 End Stage Renal Disease ClinicalTrials.gov
    Steroids DRUG Phase PHASE1 End Stage Renal Disease ClinicalTrials.gov
    TOL101 DRUG Phase PHASE1 End Stage Renal Disease ClinicalTrials.gov
    Anti-Thymocyte Globulin DRUG Phase PHASE1 End Stage Renal Disease ClinicalTrials.gov
    Zonisamide SR 360 mg/day/ bupropion SR 360 mg/day DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Zonisamide SR 120 mg/day/ bupropion SR 360 mg/day DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Zonisamide SR 360 mg/day/ bupropion SR placebo DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Zonisamide SR 120 mg/day/ bupropion SR placebo DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Zonisamide SR placebo/ bupropion SR 360 mg/day DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Zonisamide SR placebo/ bupropion SR placebo DRUG Phase PHASE2 Obesity ClinicalTrials.gov
    Arbaclofen DRUG Phase PHASE2 Autism Spectrum Disorders ClinicalTrials.gov
    Liposome Entrapped Docetaxel (LE-DT) DRUG Phase PHASE2 Pancreatic Cancer ClinicalTrials.gov
    surgery and wafer placement (1 procedure) PROCEDURE Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    prolifespan 20 with carmustine implant (GLIADEL® Wafer) DRUG Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    surgery and catheter placement (2 procedures) PROCEDURE Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    IL13-PE38QQR DRUG Phase PHASE3 Glioblastoma Multiforme ClinicalTrials.gov
    RC-1291 HCl DRUG Phase PHASE2 Cancer Cachexia ClinicalTrials.gov
    PEG-Intron™ DRUG Phase PHASE2 Hepatitis C, Chronic ClinicalTrials.gov
    Locteron™ (controlled-release interferon alpha 2b) DRUG Phase PHASE2 Hepatitis C, Chronic ClinicalTrials.gov
    ribavirin DRUG Phase PHASE2 Hepatitis C, Chronic ClinicalTrials.gov
    NDV-3 investigational vaccine BIOLOGICAL Phase PHASE1 Staphylococcal Infections ClinicalTrials.gov
    ST101 DRUG Phase PHASE2 Essential Tremor ClinicalTrials.gov
    Naltrexone DRUG Phase PHASE1 Pain, Postoperative ClinicalTrials.gov
    Fentanyl DRUG Phase PHASE1 Pain, Postoperative ClinicalTrials.gov
    LEP-ETU DRUG Phase PHASE2 Breast Cancer ClinicalTrials.gov
    Fentanyl sublingual spray DRUG Phase PHASE3 Mucositis ClinicalTrials.gov
    Vascugel BIOLOGICAL Phase PHASE1 Hemodialysis Access ClinicalTrials.gov
    surgery PROCEDURE Phase PHASE1 Malignant Glioma ClinicalTrials.gov
    pegylated IFNa2b BIOLOGICAL Phase PHASE1 Hepatitis C ClinicalTrials.gov
    Locteron (controlled-release interferon alpha 2b) OTHER Phase PHASE1 Hepatitis C ClinicalTrials.gov
    PWT33597 mesylate DRUG Phase PHASE1 Malignancies ClinicalTrials.gov
    Naltrexone SR 32 mg DRUG Phase PHASE2 Obsessive-Compulsive Disorder ClinicalTrials.gov
    Naltrexone 32 mg and fluoxetine 60 mg DRUG Phase PHASE2 Obsessive-Compulsive Disorder ClinicalTrials.gov
    Fluoxetine 60 mg DRUG Phase PHASE2 Obsessive-Compulsive Disorder ClinicalTrials.gov
    TTI-1612 DRUG Phase PHASE1 Interstitial Cystitis ClinicalTrials.gov
    INV-144 DRUG Phase PHASE2 Hypertension ClinicalTrials.gov
    Active Control DRUG Phase PHASE2 Hypertension ClinicalTrials.gov
    STX209 DRUG Preclinical Fragile X Syndrome ClinicalTrials.gov
    2 x 10 mg Natura-alpha capsules DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    10 mg Natura-alpha capsule and 10 mg placebo capsule DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    placebo capsule DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    Dronabinol Oral Solution DRUG Phase PHASE1 Bioavailability ClinicalTrials.gov
    Dronabinol Capsules, 5 mg DRUG Phase PHASE1 Bioavailability ClinicalTrials.gov
    LErafAON DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    Naltrexone 50 mg DRUG Phase PHASE1 Pain ClinicalTrials.gov
    Fentanyl citrate injection 100 µg intravenously DRUG Phase PHASE1 Pain ClinicalTrials.gov
    Actiq® 400 µg transmucosally DRUG Phase PHASE1 Pain ClinicalTrials.gov
    Fentanyl 400 µg sublingual spray DRUG Phase PHASE1 Pain ClinicalTrials.gov
    Nexavar DRUG Phase EARLY_PHASE1 Carcinoma, Hepatocellular ClinicalTrials.gov
    Obalon Gastric Balloon DEVICE Preclinical Obesity ClinicalTrials.gov
    Liposome-encapsulated SN38 DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    STX209 (arbaclofen) DRUG Phase PHASE3 Autism Spectrum Disorders ClinicalTrials.gov
    LE-DT DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    LErafAON-ETU DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    naltrexone SR 32 mg/ bupropion SR 360 mg daily DRUG Phase PHASE2 Depression ClinicalTrials.gov
    accupril, alpha lipoic acid DRUG Approved Diabetes ClinicalTrials.gov
    accupril, placebo DRUG Approved Diabetes ClinicalTrials.gov
    Quinapril (Accupril) plus Alpha Lipoic Acid DRUG Approved Diabetes ClinicalTrials.gov
    ACRX-100 BIOLOGICAL Phase PHASE1 Heart Failure ClinicalTrials.gov
    RC-1291 DRUG Phase PHASE2 Cancer Cachexia ClinicalTrials.gov
    Placebo plus olanzapine DRUG Phase PHASE2 Schizophrenia ClinicalTrials.gov
    zonisamide SR plus olanzapine DRUG Phase PHASE2 Schizophrenia ClinicalTrials.gov
    STX107 DRUG Phase PHASE2 Fragile X Syndrome ClinicalTrials.gov
    Nexagon® vehicle DRUG Phase PHASE2 Venous Ulcer ClinicalTrials.gov
    Nexagon® DRUG Phase PHASE2 Venous Ulcer ClinicalTrials.gov
    Paclitaxel for injection (Taxol) DRUG Phase PHASE1 Neoplasm ClinicalTrials.gov
    Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) DRUG Phase PHASE1 Neoplasm ClinicalTrials.gov
    JVS-100 or placebo BIOLOGICAL Phase PHASE1 Median Sternotomy ClinicalTrials.gov
    Synvisc-One DEVICE Phase PHASE2 Osteoarthritis of the Knee ClinicalTrials.gov
    Hydros-TA Joint Therapy DEVICE Phase PHASE2 Osteoarthritis of the Knee ClinicalTrials.gov
    Hydros Joint Therapy DEVICE Phase PHASE2 Osteoarthritis of the Knee ClinicalTrials.gov
    Ancillary therapy BEHAVIORAL Phase PHASE2 Nicotine Dependence ClinicalTrials.gov
    NB32 DRUG Phase PHASE2 Nicotine Dependence ClinicalTrials.gov
    Elidel (pimecrolimus cream, 1%) Hylatopic Plus Emollient Foam (non-medicated device) DEVICE Phase PHASE4 Eczema ClinicalTrials.gov
    SKP-1041 (experimental formulation of zaleplon) DRUG Phase PHASE2 Sleep Disorder ClinicalTrials.gov
    Temozolomide with radiation therapy DRUG Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Radiation therapy PROCEDURE Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Surgery for placement PROCEDURE Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Liposome Entrapped Paclitaxel Easy to Use DRUG Phase PHASE1 Neoplasm ClinicalTrials.gov
    Liposome Encapsulated Mitoxantrone (LEM) DRUG Phase PHASE1 Tumors ClinicalTrials.gov
    losartan and HCTZ DRUG Phase PHASE4 Hypertension ClinicalTrials.gov
    amlodipine and olmesartan DRUG Phase PHASE4 Hypertension ClinicalTrials.gov
    Usual Care BEHAVIORAL Phase PHASE3 Obesity ClinicalTrials.gov
    CLI BEHAVIORAL Phase PHASE3 Obesity ClinicalTrials.gov
    NB DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    Matching placebo DRUG Phase PHASE2 Nasolabial Folds ClinicalTrials.gov
    TAT4 Gel DRUG Phase PHASE2 Nasolabial Folds ClinicalTrials.gov
    Cavosonstat DRUG Phase PHASE2 Cystic Fibrosis ClinicalTrials.gov
    TR-701 FA tablets DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    TR-701 FA for injection, 200 mg/vial DRUG Phase PHASE1 Bacterial Infections ClinicalTrials.gov
    Naltrexone SR 32 mg/bupropion SR 360 mg/day DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    SS1(dsFv)-PE38 DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    Triamcinolone Acetonide DRUG Phase PHASE3 Osteoarthritis of the Knee ClinicalTrials.gov
    Hydros-TA DEVICE Phase PHASE3 Osteoarthritis of the Knee ClinicalTrials.gov
    Hydros DEVICE Phase PHASE3 Osteoarthritis of the Knee ClinicalTrials.gov
    Mesalamine Enema DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    Zoenasa-1:4 DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    JVS-100 30 mg dose injection BIOLOGICAL Phase PHASE2 Ischemic Heart Failure ClinicalTrials.gov
    Placebo Injection BIOLOGICAL Phase PHASE2 Ischemic Heart Failure ClinicalTrials.gov
    JVS-100 15 mg dose Injection BIOLOGICAL Phase PHASE2 Ischemic Heart Failure ClinicalTrials.gov
    Linezolid DRUG Phase PHASE2 Infectious Skin Diseases ClinicalTrials.gov
    Radezolid DRUG Phase PHASE2 Infectious Skin Diseases ClinicalTrials.gov
    Moxifloxacin DRUG Phase PHASE1 Heart Repolarization ClinicalTrials.gov
    Naltrexone HCl/bupropion HCl DRUG Phase PHASE1 Heart Repolarization ClinicalTrials.gov
    Ad/PNP and fludarabine monophosphate GENETIC Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    RM-131 DRUG Phase PHASE2 Anorexia Nervosa ClinicalTrials.gov
    Naltrexone SR 32 mg/Bupropion SR 360 mg /day DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    Naltrexone SR 16 mg/Bupropion SR 360 mg /day DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    Aneustat (OMN54) DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    Dalbavancin DRUG Phase PHASE1 Bacterial Infections. ClinicalTrials.gov
    Placebo Control (diluted autologous peripheral blood) BIOLOGICAL Phase PHASE3 Critical Limb Ischemia (CLI) ClinicalTrials.gov
    Autologous Bone Marrow Concentrate (aBMC) BIOLOGICAL Phase PHASE3 Critical Limb Ischemia (CLI) ClinicalTrials.gov
    Nexagon® High Dose DRUG Phase PHASE2 Venous Leg Ulcers ClinicalTrials.gov
    Nexagon® Low Dose DRUG Phase PHASE2 Venous Leg Ulcers ClinicalTrials.gov
    Placebo Gel DRUG Phase PHASE2 Excess Submental Fat ("Double Chin") ClinicalTrials.gov
    XAF5 Gel DRUG Phase PHASE2 Excess Submental Fat ("Double Chin") ClinicalTrials.gov
    TAT4 Gel concentration B DRUG Phase PHASE1 Nasolabial Folds ClinicalTrials.gov
    TAT4 Gel concentration A DRUG Phase PHASE1 Nasolabial Folds ClinicalTrials.gov
    EFB0026 (metformin immediate-release) DRUG Phase PHASE1 Type 2 Diabetes Mellitus ClinicalTrials.gov
    EFB0027 (metformin delayed release) DRUG Phase PHASE1 Type 2 Diabetes Mellitus ClinicalTrials.gov
    Relamorelin DRUG Phase PHASE1 Gastric Motility ClinicalTrials.gov
    Azithromycin DRUG Phase PHASE3 Community Acquired Pneumonia ClinicalTrials.gov
    Linezolid Placebo DRUG Phase PHASE3 Community Acquired Pneumonia ClinicalTrials.gov
    Zileuton extended release DRUG Phase PHASE4 Asthma ClinicalTrials.gov
    Rifampin DRUG Phase PHASE1 Drug Interaction Potentiation ClinicalTrials.gov
    N91115 DRUG Phase PHASE1 Drug Interaction Potentiation ClinicalTrials.gov
    CTO alone DRUG Phase PHASE1 Malignant Glioma (WHO Grade III or IV) ClinicalTrials.gov
    CTO and Bevacizumab DRUG Phase PHASE1 Malignant Glioma (WHO Grade III or IV) ClinicalTrials.gov
    Vancomycin/Linezolid DRUG Phase PHASE3 Abscess ClinicalTrials.gov
    IV Dalbavancin DRUG Phase PHASE3 Abscess ClinicalTrials.gov
    Metformin DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Naltrexone/Bupropion DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    XAF5, concentration C DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    XAF5, concentration B DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    XAF5, concentration A DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Xalatan DRUG Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    Latanoprost Punctal Plug Delivery System DRUG Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    45 mg dose of JVS-100 BIOLOGICAL Phase PHASE1 Ischemic Heart Failure ClinicalTrials.gov
    30 mg dose of JVS-100 BIOLOGICAL Phase PHASE1 Ischemic Heart Failure ClinicalTrials.gov
    R-baclofen DRUG Phase PHASE1 Autism ClinicalTrials.gov
    cefazolin, nafcillin, oxacillin or vancomycin DRUG Phase PHASE3 Osteomyelitis ClinicalTrials.gov
    Treatment C DRUG Approved Healthy ClinicalTrials.gov
    Treatment B DRUG Approved Healthy ClinicalTrials.gov
    Treatment A DRUG Approved Healthy ClinicalTrials.gov
    tigecycline DRUG Phase PHASE2 Skin Structure Infections ClinicalTrials.gov
    Intensive group lifestyle modification counseling BEHAVIORAL Phase PHASE3 Obesity ClinicalTrials.gov
    Naltrexone SR 32 mg/ bupropion SR 360 mg/ day DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    Oral placebo at bedtime DRUG Phase PHASE2 Osteopenia ClinicalTrials.gov
    Oral calcitonin at bedtime DRUG Phase PHASE2 Osteopenia ClinicalTrials.gov
    Oral placebo at dinnertime DRUG Phase PHASE2 Osteopenia ClinicalTrials.gov
    Oral calcitonin at dinnertime DRUG Phase PHASE2 Osteopenia ClinicalTrials.gov
    TR-701 FA DRUG Phase PHASE1 Renal Impairment ClinicalTrials.gov
    TR-701 FA single infusion DRUG Phase PHASE1 Renal Impairment ClinicalTrials.gov
    Standard of care tPA therapy for acute ischemic stroke DRUG Phase PHASE3 Acute Ischemic Stroke ClinicalTrials.gov
    Transcranial ultrasound as an adjunctive therapy to tPA DEVICE Phase PHASE3 Acute Ischemic Stroke ClinicalTrials.gov
    Met XR DRUG Phase PHASE2 Renal Insufficiency ClinicalTrials.gov
    Met DR DRUG Phase PHASE2 Renal Insufficiency ClinicalTrials.gov
    TR-701 free acid phosphate DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TR-701 di-sodium phosphate salt DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Test naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets) DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets) DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Fortical (rsCT) nasal spray DRUG Phase PHASE2 Phase 1 Pharmacodynamic Study ClinicalTrials.gov
    Oral rsCT tablet DRUG Phase PHASE2 Phase 1 Pharmacodynamic Study ClinicalTrials.gov
    Oral Placebo Tablet DRUG Phase PHASE2 Phase 1 Pharmacodynamic Study ClinicalTrials.gov
    XOPH5 Ointment DRUG Phase PHASE2 Lower Eyelid Steatoblepharon (Excess Eyelid Fat) ClinicalTrials.gov
    SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    B/A DRUG Phase EARLY_PHASE1 Osteoarthritis of the Hands ClinicalTrials.gov
    A/B DRUG Phase EARLY_PHASE1 Osteoarthritis of the Hands ClinicalTrials.gov
    JVS-100(16 mg) or placebo/16 injections BIOLOGICAL Phase PHASE2 Critical Limb Ischemia ClinicalTrials.gov
    JVS-100(8 mg) or placebo/16 injections BIOLOGICAL Phase PHASE2 Critical Limb Ischemia ClinicalTrials.gov
    JVS-100(8 mg) or placebo/8 injections BIOLOGICAL Phase PHASE2 Critical Limb Ischemia ClinicalTrials.gov
    JVS-100(4 mg) or placebo/8 injections BIOLOGICAL Phase PHASE2 Critical Limb Ischemia ClinicalTrials.gov
    Fentanyl Citrate Injection (FCI) DRUG Approved Bioavailability ClinicalTrials.gov
    Fentanyl Sublingual Spray (FSS) DRUG Approved Bioavailability ClinicalTrials.gov
    20mg/N6022 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    10mg/N6022 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    5 mg/N6022 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Dronabinol 30 mg DRUG Phase PHASE1 Drug Abuse, Medication ClinicalTrials.gov
    Dronabinol 10 mg DRUG Phase PHASE1 Drug Abuse, Medication ClinicalTrials.gov
    ATNC05 DRUG Phase PHASE2 Atypical Facial Pain ClinicalTrials.gov
    Eribulin DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    Sorafenib (Nexavar, BAY43-9006) DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    CryJ2-DNA-LAMP plasmid vaccine by intramuscular injection BIOLOGICAL Phase PHASE1 Allergic Rhinoconjunctivitis ClinicalTrials.gov
    Carfilzomib DRUG Preclinical Multiple Myeloma ClinicalTrials.gov
    Fentanyl Citrate IV DRUG Phase PHASE1 Pharmacology ClinicalTrials.gov
    Plurogel PN DRUG Phase PHASE2 Diabetic Foot Ulcer ClinicalTrials.gov
    Sorafenib DRUG Phase PHASE1 Leukemia ClinicalTrials.gov
    Vancomycin / Linezolid DRUG Phase PHASE3 Abscess ClinicalTrials.gov
    Negative Control - Intradermal Diluent BIOLOGICAL Phase EARLY_PHASE1 Cat Allergy ClinicalTrials.gov
    Positive Control - Histamine Prick BIOLOGICAL Phase EARLY_PHASE1 Cat Allergy ClinicalTrials.gov
    Positive Control - standardized cat hair allergenic extract (CAT) BIOLOGICAL Phase EARLY_PHASE1 Cat Allergy ClinicalTrials.gov
    Intradermal Human Fcγ1-Fel d1 fusion protein BIOLOGICAL Phase EARLY_PHASE1 Cat Allergy ClinicalTrials.gov
    PT2385 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    N6022 DRUG Phase PHASE1 Cystic Fibrosis ClinicalTrials.gov
    Saline Control OTHER Phase PHASE1 Allergic Rhinitis ClinicalTrials.gov
    CryJ2-DNA-LAMP plasmid vaccine by intradermal injection BIOLOGICAL Phase PHASE1 Allergic Rhinitis ClinicalTrials.gov
    IL-13-PE DRUG Phase PHASE1 Adrenocortical Carcinoma ClinicalTrials.gov
    JVS-100 BIOLOGICAL Phase PHASE2 Peripheral Arterial Disease ClinicalTrials.gov
    SL film DRUG Phase PHASE1 Opiate Dependence ClinicalTrials.gov
    SL spray DRUG Phase PHASE1 Opiate Dependence ClinicalTrials.gov
    10 mg/kg epsi-gam or placebo (6:2) DRUG Phase PHASE1 Allergy and Immunology ClinicalTrials.gov
    3 mg/kg epsi-gam or placebo (6:2) DRUG Phase PHASE1 Allergy and Immunology ClinicalTrials.gov
    1.0 mg/kg epsi-gam or placebo (6:2) DRUG Phase PHASE1 Allergy and Immunology ClinicalTrials.gov
    0.3 mg/kg epsi-gam or placebo (6:2) DRUG Phase PHASE1 Allergy and Immunology ClinicalTrials.gov
    0.1 mg/kg epsi-gam or placebo (6:2) DRUG Phase PHASE1 Allergy and Immunology ClinicalTrials.gov
    Naltrexone SR 32 mg/bupropion SR 360 mg/ day DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    Lomustine DRUG Phase PHASE1 Malignant Glioma (WHO Grade III or IV) ClinicalTrials.gov
    CTO DRUG Phase PHASE1 Malignant Glioma (WHO Grade III or IV) ClinicalTrials.gov
    fMRI scan OTHER Phase PHASE2 Obesity ClinicalTrials.gov
    PluroGel DRUG Phase PHASE2 Diabetic Foot Ulcer ClinicalTrials.gov
    PluroGel N DRUG Phase PHASE2 Diabetic Foot Ulcer ClinicalTrials.gov
    ATI-0918 DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    DOXIL/CAELYX DRUG Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Fentanyl Citrate DRUG Phase PHASE1 Pharmacokinetics and Pharmacodynamics ClinicalTrials.gov
    Nexagon® Medium Dose DRUG Phase PHASE2 Diabetic Foot Ulcers ClinicalTrials.gov
    Active DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    SM04690, 0.23mg/2mL DRUG Phase PHASE1 Moderate to Severe Osteoarthritis ClinicalTrials.gov
    SM04690, 0.07mg/2mL DRUG Phase PHASE1 Moderate to Severe Osteoarthritis ClinicalTrials.gov
    SM04690, 0.03mg/2mL DRUG Phase PHASE1 Moderate to Severe Osteoarthritis ClinicalTrials.gov
    Lisofylline DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    OC-10X DRUG Phase PHASE1 Proliferative Diabetic Retinopathy (PDR) ClinicalTrials.gov
    Placebo-controlled withTyramine DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    TR-701 FA with Tyramine DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Enteral Nimodipine DRUG Phase PHASE3 Subarachnoid Hemorrhage, Aneurysmal ClinicalTrials.gov
    EG-1962 (nimodipine microparticles) DRUG Phase PHASE3 Subarachnoid Hemorrhage, Aneurysmal ClinicalTrials.gov
    ethinyl estradiol and levonorgestrel DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    PTI-428 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    PX-12 DRUG Phase PHASE1 Metastatic Cancer ClinicalTrials.gov
    SM04646 DRUG Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    LY2940094 DRUG Phase PHASE2 Major Depressive Disorder ClinicalTrials.gov
    Anamorelin HCl DRUG Phase PHASE3 Cachexia ClinicalTrials.gov
    NDV-3 BIOLOGICAL Phase PHASE1 Vulvovaginal Candidiasis ClinicalTrials.gov
    NDV-3A BIOLOGICAL Phase PHASE1 Vulvovaginal Candidiasis ClinicalTrials.gov
    PX-866 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Placebo Solution DRUG Phase PHASE3 Dravet Syndrome ClinicalTrials.gov
    Cannabidiol Oral Solution DRUG Phase PHASE3 Dravet Syndrome ClinicalTrials.gov
    Intravenous Placebo DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Placebo Sublingual Spray DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Fentanyl 400 µg DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Fentanyl 200 µg DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Fentanyl 100 µg DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Morphine 6 mg DRUG Phase PHASE2 Acute Pain ClinicalTrials.gov
    Midazolam DRUG Phase PHASE1 VA Drug Interactions ClinicalTrials.gov
    Vehicle DRUG Phase PHASE1 Tendinopathy ClinicalTrials.gov
    SM04755 DRUG Phase PHASE1 Tendinopathy ClinicalTrials.gov
    ONT-10 BIOLOGICAL Phase PHASE1 Solid Tumors ClinicalTrials.gov
    TR-701 FA Placebo with PSE OTHER Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    TR-701 FA with PSE DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Minoxidil Solution 5% DRUG Phase PHASE2 Androgenetic Alopecia ClinicalTrials.gov
    CB-03-01 solution DRUG Phase PHASE2 Androgenetic Alopecia ClinicalTrials.gov
    Placebo Oral Tablet DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    AMXT 1501 DRUG Phase PHASE1 Neoplasms ClinicalTrials.gov
    CEM-101 DRUG Phase PHASE2 Community-Acquired Bacterial Pneumonia ClinicalTrials.gov
    Levofloxacin DRUG Phase PHASE2 Community-Acquired Bacterial Pneumonia ClinicalTrials.gov
    Weight Management Program BEHAVIORAL Phase PHASE3 Obesity ClinicalTrials.gov
    PBO DRUG Phase PHASE3 Obesity ClinicalTrials.gov
    vemurafenib DRUG Phase PHASE1 Advanced BRAF-mutant Cancers ClinicalTrials.gov
    TR-701 DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Solithromycin DRUG Phase PHASE3 Community-acquired Bacterial Pneumonia ClinicalTrials.gov
    PX-478 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Dalbavancin-matching Placebo DRUG Phase PHASE3 Abscess ClinicalTrials.gov
    Sodium lauryl sulfate OTHER Phase PHASE1 Tendinopathy ClinicalTrials.gov
    White Petrolatum OTHER Phase PHASE1 Tendinopathy ClinicalTrials.gov
    Met IR DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov
    TR-701 600mg DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    ATR-101 DRUG Phase PHASE1 Adrenocortical Carcinoma ClinicalTrials.gov
    High dose ET019002- T Cells BIOLOGICAL Phase EARLY_PHASE1 B-Cell Malignancies ClinicalTrials.gov
    Middle dose ET019002- T Cells BIOLOGICAL Phase EARLY_PHASE1 B-Cell Malignancies ClinicalTrials.gov
    Low dose ET019002- T Cells BIOLOGICAL Phase EARLY_PHASE1 B-Cell Malignancies ClinicalTrials.gov
    MRG-201 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    2% OC-10X DRUG Phase PHASE2 Proliferative Diabetic Retinopathy (PDR) ClinicalTrials.gov
    Buprenorphine Sublingual Spray DRUG Phase PHASE3 Post-operative Pain ClinicalTrials.gov
    Placebo Sublingual Spray (PSS) DRUG Phase PHASE3 Chronic Pain ClinicalTrials.gov
    Pegasys DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    Placebo for NVR 3-778 DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    NVR 3-778 DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    TR-701 FA 200 mg DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    NicoDerm CQ Patch DRUG Phase PHASE2 Smoking Cessation ClinicalTrials.gov
    CQSS2 DRUG Phase PHASE2 Smoking Cessation ClinicalTrials.gov
    SGT-94 GENETIC Phase PHASE1 Neoplasm ClinicalTrials.gov
    Impact Peptide 1.5 OTHER Approved Cystic Fibrosis ClinicalTrials.gov
    RELiZORB (immobilized lipase) cartridge DEVICE Approved Cystic Fibrosis ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE1 Non Small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    ALX-101 Gel 5% and ALX-101 Gel Vehicle DRUG Phase PHASE2 Atopic Dermatitis ClinicalTrials.gov
    ALX-101 Gel 1.5% and ALX-101 Gel Vehicle DRUG Phase PHASE2 Atopic Dermatitis ClinicalTrials.gov
    INT131 DRUG Phase PHASE2 Multiple Sclerosis, Relapsing Remitting ClinicalTrials.gov
    Saline DRUG Phase PHASE3 Urinary Tract Infection Complicated ClinicalTrials.gov
    Piperacillin-Tazobactam DRUG Phase PHASE3 Urinary Tract Infection Complicated ClinicalTrials.gov
    Meropenem-Vaborbactam DRUG Phase PHASE3 Urinary Tract Infection Complicated ClinicalTrials.gov
    Oritavancin DRUG Preclinical Gram-Positive Bacterial Infections ClinicalTrials.gov
    Aztreonam DRUG Phase PHASE3 Skin and Subcutaneous Tissue Bacterial Infections ClinicalTrials.gov
    Vancomycin DRUG Phase PHASE3 Skin and Subcutaneous Tissue Bacterial Infections ClinicalTrials.gov
    Cleveland Multiport Catheter DEVICE Phase EARLY_PHASE1 Malignant Glioma ClinicalTrials.gov
    Gadolinium DTPA DRUG Phase EARLY_PHASE1 Malignant Glioma ClinicalTrials.gov
    Topotecan DRUG Phase EARLY_PHASE1 Malignant Glioma ClinicalTrials.gov
    Obalon Balloon System DEVICE Preclinical Obesity ClinicalTrials.gov
    Placebo-Day 1 only DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    ceftriaxone DRUG Phase PHASE3 Uncomplicated Urogenital Gonorrhea ClinicalTrials.gov
    carfilzomib, lenalidomide plus dexamethasone DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Cetuximab (CRC) DRUG Phase PHASE1 Incurable Metastatic Colorectal Carcinoma ClinicalTrials.gov
    PX-866 (CRC) DRUG Phase PHASE1 Incurable Metastatic Colorectal Carcinoma ClinicalTrials.gov
    Cetuximab (SCCHN) DRUG Phase PHASE1 Incurable Metastatic Colorectal Carcinoma ClinicalTrials.gov
    PX-866 (SCCHN) DRUG Phase PHASE1 Incurable Metastatic Colorectal Carcinoma ClinicalTrials.gov
    Zofran DRUG Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Oxycodone Hydrochloride DRUG Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Morphine DRUG Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    SGT-53 GENETIC Phase PHASE1 Neoplasm ClinicalTrials.gov
    Solithromycin (CEM-101) DRUG Phase PHASE2 Uncomplicated Urogenital Gonorrhea ClinicalTrials.gov
    Thrombosomes BIOLOGICAL Phase EARLY_PHASE1 Healthy ClinicalTrials.gov
    Ipamorelin DRUG Phase PHASE2 Gastrointestinal Dysmotility ClinicalTrials.gov
    Saline Solution for Injection DRUG Phase PHASE2 Gastrointestinal Dysmotility ClinicalTrials.gov
    XAF5 (concentration B: 0.035%) DRUG Phase PHASE2 Steatoblepharon ClinicalTrials.gov
    XAF5 (concentration A: 0.1%) DRUG Phase PHASE2 Steatoblepharon ClinicalTrials.gov
    Human primary Retinal Pigment Epithelial (HuRPE) cells BIOLOGICAL Phase EARLY_PHASE1 Leber Congenital Amaurosis, Retinitis Pigmentosa ClinicalTrials.gov
    Nimodipine Microparticles DRUG Phase PHASE1 Ruptured Cerebral Aneurysm ClinicalTrials.gov
    Nimodipine DRUG Phase PHASE1 Ruptured Cerebral Aneurysm ClinicalTrials.gov
    OPT-821 BIOLOGICAL Phase PHASE2 Sarcoma ClinicalTrials.gov
    Trivalent ganglioside vaccine BIOLOGICAL Phase PHASE2 Sarcoma ClinicalTrials.gov
    Nutrition and Lifestyle Program BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Sham Device DEVICE Approved Obesity ClinicalTrials.gov
    Obalon Intragastric Balloons DEVICE Approved Obesity ClinicalTrials.gov
    Implantation of Morphine Sulfate delivering programmable pump DEVICE Phase PHASE2 Cancers ClinicalTrials.gov
    Scopolamine DRUG Phase PHASE2 Motion Sickness ClinicalTrials.gov
    HTI-2088 DRUG Phase PHASE1 Diabetes ClinicalTrials.gov
    Naltrexone HCl/Bupropion HCl ER DRUG Phase PHASE4 Obesity ClinicalTrials.gov
    Buprenorphine DRUG Phase PHASE3 Pain ClinicalTrials.gov
    Latanoprost Punctal Plug Delivery System (L-PPDS) DRUG Phase PHASE2 Ocular Hypertension ClinicalTrials.gov
    Analatro DRUG Phase PHASE3 Latrodectism ClinicalTrials.gov
    Placebo to match solithromycin OTHER Phase PHASE3 Community-acquired Bacterial Pneumonia ClinicalTrials.gov
    TR701 FA DRUG Phase PHASE2 Major Cutaneous Abscess ClinicalTrials.gov
    RELiZORB DEVICE Approved Exocrine Pancreatic Insufficiency ClinicalTrials.gov
    Eflornithine DRUG Phase PHASE3 Anaplastic Astrocytoma ClinicalTrials.gov
    AMV564 14-Day CIV DRUG Phase PHASE1 Myelodysplastic Syndrome (MDS) ClinicalTrials.gov
    Rituximab DRUG Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    FOR46 DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    IV Vancomycin DRUG Phase PHASE3 Wound Infection ClinicalTrials.gov
    Single-Dose IV Oritavancin Diphosphate DRUG Phase PHASE3 Wound Infection ClinicalTrials.gov
    FP-1039 DRUG Phase PHASE2 Endometrial Cancers With FGFR2 Mutations ClinicalTrials.gov
    AR101 BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Two-Stage Exchange Arthroplasty PROCEDURE Phase PHASE1 Prosthetic Joint Infection ClinicalTrials.gov
    Phage Therapy BIOLOGICAL Phase PHASE1 Prosthetic Joint Infection ClinicalTrials.gov
    AMV564 BIOLOGICAL Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Coconut Oil DRUG Phase PHASE1 Interstitial Cystitis ClinicalTrials.gov
    Peppermint oil DRUG Phase PHASE1 Interstitial Cystitis ClinicalTrials.gov
    Stella (TM) Mobile Application DEVICE Approved Post-partum Depression ClinicalTrials.gov
    FPA144 DRUG Preclinical Recurrent Bladder Cancer ClinicalTrials.gov
    OMN54 DRUG Preclinical Prostate Cancer ClinicalTrials.gov
    FPA008 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Clarithromycin DRUG Phase PHASE1 Drug Drug Interaction ClinicalTrials.gov
    ATI-2173 DRUG Phase PHASE1 Drug Drug Interaction ClinicalTrials.gov
    %5 dextrose for infusion BIOLOGICAL Phase PHASE1 Traumatic Brain Injury ClinicalTrials.gov
    PNT001 BIOLOGICAL Phase PHASE1 Traumatic Brain Injury ClinicalTrials.gov
    Xeroform DRUG Phase PHASE1 Wound Infection ClinicalTrials.gov
    Bacteriophage cocktail spray BIOLOGICAL Phase PHASE1 Wound Infection ClinicalTrials.gov
    RAD1901 DRUG Phase PHASE1 Metastatic Breast Cancer ClinicalTrials.gov
    Senaparib DRUG Phase PHASE2 mCRPC ClinicalTrials.gov
    PT-112 DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Temozolomide DRUG Phase EARLY_PHASE1 Childhood CNS Tumor ClinicalTrials.gov
    Radiation RADIATION Phase EARLY_PHASE1 Childhood CNS Tumor ClinicalTrials.gov
    Recombinant EphB4-HSA Fusion Protein BIOLOGICAL Phase PHASE2 Castration Levels of Testosterone ClinicalTrials.gov
    Vincristine Liposomal DRUG Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Laboratory Biomarker Analysis OTHER Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE1 Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome ClinicalTrials.gov
    Dapagliflozin DRUG Phase PHASE2 Diabetes ClinicalTrials.gov
    YG1699 DRUG Phase PHASE2 Diabetes ClinicalTrials.gov
    PTX-COVID19-B BIOLOGICAL Phase PHASE1 Covid19 Vaccine ClinicalTrials.gov
    Placebo powder provided in capsules BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    AR101 powder provided in capsules BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    Placebo powder provided in capsules & sachets BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    AR101 powder provided in capsules & sachets BIOLOGICAL Phase PHASE3 Peanut Allergy ClinicalTrials.gov
    Treatment B with smoking education (control) DEVICE Approved Nicotine Addiction ClinicalTrials.gov
    Treatment A with device Clickotine® (Active intervention) DEVICE Approved Nicotine Addiction ClinicalTrials.gov
    Vorinostat DRUG Phase PHASE2 Cutaneous T-Cell Lymphoma/Mycosis Fungoides ClinicalTrials.gov
    Cobomarsen DRUG Phase PHASE2 Cutaneous T-Cell Lymphoma/Mycosis Fungoides ClinicalTrials.gov
    RAD140 DRUG Phase PHASE1 Hormone Receptor Positive Malignant Neoplasm of Breast ClinicalTrials.gov
    Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013 BIOLOGICAL Preclinical Hemophilia ClinicalTrials.gov
    Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013 BIOLOGICAL Preclinical Hemophilia ClinicalTrials.gov
    Sham balloon placement OTHER Approved Stress Urinary Incontinence ClinicalTrials.gov
    Vesair Balloon DEVICE Approved Stress Urinary Incontinence ClinicalTrials.gov
    Pharmacogenomic Study OTHER Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Pharmacological Study OTHER Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    HIF-2alpha Inhibitor PT2385 DRUG Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    D-4517.2 DRUG Phase PHASE1 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    Standard of Care PROCEDURE Phase PHASE1 Pressure Ulcer ClinicalTrials.gov
    Vehicle Gel DRUG Phase PHASE2 Neurofibromatosis 1 ClinicalTrials.gov
    NFX-179 Gel DRUG Phase PHASE2 Neurofibromatosis 1 ClinicalTrials.gov
    Viread 300Mg Tablet DRUG Phase PHASE2 Chronic Hepatitis b ClinicalTrials.gov
    Vebicorvir 300mg DRUG Phase PHASE2 Chronic Hepatitis b ClinicalTrials.gov
    ATI-2173 25mg DRUG Phase PHASE2 Chronic Hepatitis b ClinicalTrials.gov
    Go Home tablet with linked GoSpiro and 3230 Pulse Oximeter DEVICE Approved Pulmonary Disease, Chronic Obstructive ClinicalTrials.gov
    Lorecivivint DRUG Phase PHASE3 Osteoarthritis of the Knee ClinicalTrials.gov
    XT-150 BIOLOGICAL Phase PHASE1 Osteoarthritis, Spine ClinicalTrials.gov
    Tenofovir 300Mg Oral Tablet DRUG Phase PHASE1 Drug Interaction ClinicalTrials.gov
    ATI-2173 50 mg DRUG Phase PHASE1 Drug Interaction ClinicalTrials.gov
    AR101 - Peanut protein capsule BIOLOGICAL Phase PHASE2 Peanut Allergy ClinicalTrials.gov
    recombinant albumin fusion protein sEphB4-HSA BIOLOGICAL Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific ClinicalTrials.gov
    CST-2032, matching placebo for CST-2032, CST-107 DRUG Phase PHASE1 Mild Cognitive Impairment (MCI) ClinicalTrials.gov
    ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL DRUG Phase PHASE1 Latrodectism ClinicalTrials.gov
    Placebo powder BIOLOGICAL Phase PHASE2 Hen Egg Allergy ClinicalTrials.gov
    AR201 powder BIOLOGICAL Phase PHASE2 Hen Egg Allergy ClinicalTrials.gov
    500 mg resveratrol as JOTROL administered to assess influence of food DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    700 mg resveratrol as JOTROL DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    500 mg resveratrol as JOTROL DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    200 mg resveratrol as JOTROL DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    Staccato Alprazolam 1 mg DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Topical vehicle solution DRUG Phase PHASE2 Androgenetic Alopecia ClinicalTrials.gov
    Topical SM04554 solution DRUG Phase PHASE2 Androgenetic Alopecia ClinicalTrials.gov
    BIO-106 DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    BT051 3500mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BT051 1500mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BT051 700mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BT051 300mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BT051 100mg DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MDR-103 BIOLOGICAL Phase PHASE2 Kidney Transplant Rejection ClinicalTrials.gov
    Control: Zyrtec DRUG Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    JDP-205 IM DRUG Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    JDP-205 IV low dose DRUG Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    JDP-205 IV high dose DRUG Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    RBN-3143 DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    AB-106 DRUG Phase PHASE2 Non Small Cell Lung Cancer ClinicalTrials.gov
    Palliative radiotherapy RADIATION Phase PHASE1 Metastasis ClinicalTrials.gov
    XRD-0394 DRUG Phase PHASE1 Metastasis ClinicalTrials.gov
    PT-112 Injection DRUG Phase PHASE2 Advanced Solid Tumors ClinicalTrials.gov
    TTHX1114(NM141) DRUG Phase PHASE2 Fuchs' Endothelial Dystrophy ClinicalTrials.gov
    ARTS-011 DRUG Phase PHASE1 Chinese Healthy Volunteer ClinicalTrials.gov
    LQT-1213 DRUG Phase PHASE1 Long QT Syndrome ClinicalTrials.gov
    Isuzinaxib (APX-115) DRUG Phase PHASE2 Contrast Induced Acute Kidney Injury ClinicalTrials.gov
    Acetaminophen Alone DRUG Phase PHASE2 Migraine With or Without Aura ClinicalTrials.gov
    Naltrexone Alone (regular dose) DRUG Phase PHASE2 Migraine With or Without Aura ClinicalTrials.gov
    Naltrexone and Acetaminophen-High Dose DRUG Phase PHASE2 Migraine With or Without Aura ClinicalTrials.gov
    Naltrexone and Acetaminophen DRUG Phase PHASE2 Migraine With or Without Aura ClinicalTrials.gov
    Bacteriophage DRUG Phase PHASE2 Prosthetic Joint Infection ClinicalTrials.gov
    TTHX1114 DRUG Phase PHASE2 Corneal Endothelial Dystrophy ClinicalTrials.gov
    CEND-1 DRUG Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    ASN004 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    High Dose RBT-1 DRUG Phase PHASE2 AKI ClinicalTrials.gov
    Low Dose RBT-1 DRUG Phase PHASE2 AKI ClinicalTrials.gov
    TACH101 DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    AdVEGFXC1 BIOLOGICAL Phase PHASE1 Coronary Artery Disease ClinicalTrials.gov
    Tagraxofusp-erzs BIOLOGICAL Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Digital Control DEVICE Approved Social Anxiety Disorder ClinicalTrials.gov
    ABM-01 DEVICE Approved Social Anxiety Disorder ClinicalTrials.gov
    ITI-3000 DRUG Phase PHASE1 Merkel Cell Carcinoma ClinicalTrials.gov
    Digital ACT DEVICE Approved Fibromyalgia ClinicalTrials.gov
    Surgical Resection OTHER Phase PHASE4 NSCLC ClinicalTrials.gov
    Standard of care neoadjuvant therapy DRUG Phase PHASE4 NSCLC ClinicalTrials.gov
    Nivolumab plus Platinum Doublet Chemotherapy DRUG Phase PHASE4 NSCLC ClinicalTrials.gov
    Aliya Pulsed Electric Fields (PEF) ablation DEVICE Phase PHASE4 NSCLC ClinicalTrials.gov
    BBP-671 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    MDR-101 BIOLOGICAL Phase PHASE3 Kidney Transplant Rejection ClinicalTrials.gov
    Sham Injection PROCEDURE Phase PHASE2 Retinitis Pigmentosa ClinicalTrials.gov
    Gene Therapy Product-MCO-010 BIOLOGICAL Phase PHASE2 Retinitis Pigmentosa ClinicalTrials.gov
    SM08502 DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    APX-115 DRUG Phase PHASE2 COVID-19 ClinicalTrials.gov
    Modified FOLFOX6 DRUG Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    Bemarituzumab BIOLOGICAL Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    CSX-1004 BIOLOGICAL Phase PHASE1 Opioid Overdose ClinicalTrials.gov
    TNP-2092 for injection DRUG Phase PHASE1 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) ClinicalTrials.gov
    EXG34217 BIOLOGICAL Phase PHASE1 Telomere Biology Disorders With Bone Marrow Failure ClinicalTrials.gov
    AB-2004 DRUG Phase PHASE2 Autism Spectrum Disorder (ASD) ClinicalTrials.gov
    Inhaled Nitric Oxide (iNO) DEVICE Approved Hypertension, Pulmonary ClinicalTrials.gov
    Injection needle DEVICE Phase PHASE1 Leber Hereditary Optic Neuropathy (LHON) ClinicalTrials.gov
    NR082 Injection DRUG Phase PHASE1 Leber Hereditary Optic Neuropathy (LHON) ClinicalTrials.gov
    Long Term Follow-Up DRUG Preclinical Menkes Disease ClinicalTrials.gov
    QTORIN 3.9% rapamycin anhydrous gel DRUG Phase PHASE3 Pachyonychia Congenita ClinicalTrials.gov
    CEL383 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Pembrolizumab + sEphB4-HSA DRUG Phase PHASE2 Metastatic Urothelial Carcinoma ClinicalTrials.gov
    CST-103, CST-107, matching placebo DRUG Phase PHASE2 Freezing of Gait Symptoms in Parkinson's Disease ClinicalTrials.gov
    QXL138AM Injection every 2 weeks by IV Infusion BIOLOGICAL Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Observational OTHER Preclinical Retinitis Pigmentosa ClinicalTrials.gov
    sEphB4-HSA DRUG Phase PHASE2 Kaposi Sarcoma ClinicalTrials.gov
    DMX-1002 DRUG Phase PHASE1 Opiate Withdrawal Syndrome ClinicalTrials.gov
    Part B: Safusidenib Erbumine DRUG Phase EARLY_PHASE1 Glioma ClinicalTrials.gov
    Surgery (maximal resection) PROCEDURE Phase EARLY_PHASE1 Glioma ClinicalTrials.gov
    Part A: Safusidenib Erbumine DRUG Phase EARLY_PHASE1 Glioma ClinicalTrials.gov
    Low-Dose Naltrexone and Acetaminophen Combination DRUG Phase PHASE2 Migraine With or Without Aura ClinicalTrials.gov
    AXT107 0.5 mg DRUG Phase PHASE1 Diabetic Macular Edema (DME) ClinicalTrials.gov
    AXT107 0.25 mg DRUG Phase PHASE1 Diabetic Macular Edema (DME) ClinicalTrials.gov
    AXT107 0.1 mg DRUG Phase PHASE1 Diabetic Macular Edema (DME) ClinicalTrials.gov
    Recombinant human plasma gelsolin (Rhu-pGSN) DRUG Phase PHASE2 Sars-CoV2 ClinicalTrials.gov
    PTX-022 DRUG Phase PHASE3 Pachyonychia Congenita ClinicalTrials.gov
    Placebo Nasal Gel DRUG Phase PHASE2 Motion Sickness, Space ClinicalTrials.gov
    DPI-386 Nasal Gel DRUG Phase PHASE2 Motion Sickness, Space ClinicalTrials.gov
    Genetic: GC301 BIOLOGICAL Approved Infantile-onset Pompe Disease ClinicalTrials.gov
    Diphenhydramine DRUG Phase PHASE3 Acute Urticaria ClinicalTrials.gov
    JDP-205 Injection DRUG Phase PHASE3 Acute Urticaria ClinicalTrials.gov
    AL01211 DRUG Phase PHASE2 Fabry Disease ClinicalTrials.gov
    IMC-002 BIOLOGICAL Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Placebo Ophthalmic Solution DRUG Phase PHASE2 Dry Eye Disease ClinicalTrials.gov
    ST-100 Ophthalmic Solution DRUG Phase PHASE2 Dry Eye Disease ClinicalTrials.gov
    KN-002 DRUG Phase PHASE1 Asthma COPD ClinicalTrials.gov
    Vehicle (placebo) OTHER Phase PHASE1 Corneal Endothelial Dystrophy ClinicalTrials.gov
    Pulsed electric field treatment using the Aliya System DEVICE Approved Non Small Cell Lung Cancer ClinicalTrials.gov
    ABT-101 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    HPN424 Fixed SC BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    HPN424 2 Prime Step IV 450 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    HPN424 2 Prime Step IV 300 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    HPN424 1 Prime Step IV 225-300 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    HPN424 Prime Step IV 36 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    HPN424 Fixed IV 1.3 to 150 ng/kg BIOLOGICAL Phase PHASE1 Advanced Prostate Cancer ClinicalTrials.gov
    Minoxidil 5% Topical Solution DRUG Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    active ingredient-free vehicle solution to DLQ01 DRUG Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    prostaglandin F2a analogue in vehicle solution low dose DRUG Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    prostaglandin F2a analogue in vehicle solution high dose DRUG Phase PHASE1 Androgenetic Alopecia ClinicalTrials.gov
    AMT-151 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Immunosuppressive Agents DRUG Phase PHASE2 Kidney Transplant Rejection ClinicalTrials.gov
    MDR-102 BIOLOGICAL Phase PHASE2 Kidney Transplant Rejection ClinicalTrials.gov
    SAT-001(Software as Medical Device) DEVICE Approved Children Myopia ClinicalTrials.gov
    Gene Therapy-vMCO-010 BIOLOGICAL Phase PHASE2 Stargardt Disease ClinicalTrials.gov
    ST-100 (vezocolmitide) DRUG Phase PHASE3 Dry Eye Disease ClinicalTrials.gov
    Single-Dose IV Oritavancin Diphosphate and Warfarin 24 hour post dose DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Single-Dose IV Oritavancin Diphosphate and Warfarin DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    CT-100-D-004-B DEVICE Approved Multiple Sclerosis ClinicalTrials.gov
    CT-100-D-004-A DEVICE Approved Multiple Sclerosis ClinicalTrials.gov
    Bezlutifan DRUG Phase PHASE1 ccRCC ClinicalTrials.gov
    Cabozantinib DRUG Phase PHASE1 ccRCC ClinicalTrials.gov
    Nivolumab DRUG Phase PHASE1 ccRCC ClinicalTrials.gov
    MK-3795 DRUG Phase PHASE1 ccRCC ClinicalTrials.gov
    Panitumumab DRUG Phase PHASE1 Castration-resistant Prostate Cancer ClinicalTrials.gov
    FOLFIRI Protocol DRUG Phase PHASE1 Castration-resistant Prostate Cancer ClinicalTrials.gov
    Prednisone DRUG Phase PHASE1 Castration-resistant Prostate Cancer ClinicalTrials.gov
    Abiraterone DRUG Phase PHASE1 Castration-resistant Prostate Cancer ClinicalTrials.gov
    Vehicle control DRUG Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    OTT166 DRUG Phase PHASE2 Diabetic Retinopathy ClinicalTrials.gov
    Triptorelin Injection DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Prostate SBRT with Focal Boost RADIATION Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    CLN-978 DRUG Phase PHASE1 NHL ClinicalTrials.gov
    Thrombosomes® BIOLOGICAL Preclinical Bleeding ClinicalTrials.gov
    Placebo (D5W) DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Standard platelet concentrate BIOLOGICAL Phase PHASE2 Thoracic Aortic Dissection ClinicalTrials.gov
    NFX-179 Gel 1.50% DRUG Phase PHASE2 Epidermal Nevi ClinicalTrials.gov
    MDR product DRUG Preclinical Immune Tolerance ClinicalTrials.gov
    2 Prime Step IV 900-14000 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Cancers Associated With Mesothelin Expression ClinicalTrials.gov
    HPN536 1 Prime Step IV 600-1200 ng/kg Target BIOLOGICAL Phase PHASE1 Advanced Cancers Associated With Mesothelin Expression ClinicalTrials.gov
    HPN536 Fixed IV 6 to 560 ng/kg BIOLOGICAL Phase PHASE1 Advanced Cancers Associated With Mesothelin Expression ClinicalTrials.gov
    Sub-Q Injection OTHER Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    Deep muscle injection OTHER Phase PHASE1 Acute Urticaria ClinicalTrials.gov
    Sham OTHER Phase PHASE3 Lumbosacral Radiculopathy ClinicalTrials.gov
    SL-401 9 µg/kg/day DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    SL-401 7 µg/kg/day DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    SEAL Device DEVICE Approved Aneurysms Saccular ClinicalTrials.gov
    CLN-049 DRUG Phase PHASE1 Relapsed/Refractory Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    AXT107 High Dose DRUG Phase PHASE1 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    AXT107 Mid Dose DRUG Phase PHASE1 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    AXT107 Low Dose DRUG Phase PHASE1 Neovascular Age-related Macular Degeneration ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE3 Advanced Cholangiocarcinoma ClinicalTrials.gov
    BGJ398 DRUG Phase PHASE3 Advanced Cholangiocarcinoma ClinicalTrials.gov
    Ruxolitinib DRUG Phase PHASE2 Myelofibrosis ClinicalTrials.gov
    ALMB-0168 DRUG Phase PHASE2 Advanced Solid Tumors With Bone Only Metastasis ClinicalTrials.gov
    Rabeprazole sodium enteric-coated tablets DRUG Phase PHASE1 Helicobacter Pylori Infection ClinicalTrials.gov
    TNP-2092 capsules placebo DRUG Phase PHASE1 Helicobacter Pylori Infection ClinicalTrials.gov
    TNP-2092 capsules DRUG Phase PHASE1 Helicobacter Pylori Infection ClinicalTrials.gov
    Tuohy epidural needle DEVICE Phase PHASE3 Lumbosacral Radiculopathy ClinicalTrials.gov
    Clonidine Micropellets DRUG Phase PHASE3 Lumbosacral Radiculopathy ClinicalTrials.gov
    Other (e.g., promethazine, meclizine) DRUG Phase PHASE2 Motion Sickness, Space ClinicalTrials.gov
    AT-100 BIOLOGICAL Phase PHASE1 Bronchopulmonary Dysplasia ClinicalTrials.gov
    Minocin (minocycline) for Injection DRUG Phase PHASE1 Normal Healthy Volunteers ClinicalTrials.gov
    Vehicle comparator DRUG Phase PHASE2 BCCs in Gorlin Syndrome Patients ClinicalTrials.gov
    Long-Term Safety Follow-up DRUG Preclinical Lumbosacral Radiculopathy ClinicalTrials.gov
    CFT8634 DRUG Phase PHASE1 Synovial Sarcoma ClinicalTrials.gov
    Dexamethasone Oral DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    GFH018 DRUG Phase PHASE2 NSCLC, Stage III ClinicalTrials.gov
    Thoracic Radiation Therapy (TRT) RADIATION Phase PHASE2 NSCLC, Stage III ClinicalTrials.gov
    Toripalimab DRUG Phase PHASE2 NSCLC, Stage III ClinicalTrials.gov
    ETX-4143 2.0 DEVICE Approved Eye Pain ClinicalTrials.gov
    KLN-1010 DRUG Phase PHASE1 Multiple Myeloma in Relapse ClinicalTrials.gov
    Conditioning chemotherapy followed by AbTCR (anti-CD19/CD22)-T cell infusion DRUG Phase EARLY_PHASE1 Diffuse Large B Cell Lymphoma (DLBCL) ClinicalTrials.gov
    Bacteriophage Therapy BIOLOGICAL Phase PHASE2 Osteomyelitis ClinicalTrials.gov
    AMT-253 for injection DRUG Phase PHASE1 Malignant Melanoma ClinicalTrials.gov
    nab paclitaxel DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    TTX-030 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Belzutifan DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    EB103 BIOLOGICAL Phase PHASE1 B-Cell Non-Hodgkin's Lymphoma (NHL) ClinicalTrials.gov
    Isuzinaxib DRUG Phase PHASE2 Diabetic Kidney Disease (DKD) ClinicalTrials.gov
    Senaparib 10 mg strength capsules manufactured by WuXi STA (Shanghai) Co., Ltd. DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Senaparib 10 mg strength capsules manufactured by WuXi STA (Wuxi) Co., Ltd. DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Amantadine Hydrochloride DRUG Phase PHASE2 Traumatic Brain Injury ClinicalTrials.gov
    D-Mannitol DRUG Phase PHASE2 Leigh Syndrome ClinicalTrials.gov
    TTI-0102: cysteamine-pantetheine disulfide DRUG Phase PHASE2 Leigh Syndrome ClinicalTrials.gov
    MK-4002 DRUG Phase PHASE1 Multiple Myeloma in Relapse ClinicalTrials.gov
    Immunotherapy (ipilimumab and nivolumab) BIOLOGICAL Phase PHASE2 Melanoma (Skin Cancer) ClinicalTrials.gov
    Immunotherapy (nivolumab and relatlimab) BIOLOGICAL Phase PHASE2 Melanoma (Skin Cancer) ClinicalTrials.gov
    Immunotherapy (Pembrolizumab) BIOLOGICAL Phase PHASE2 Melanoma (Skin Cancer) ClinicalTrials.gov
    Chemotherapy (dacarbazine or temozolomide) DRUG Phase PHASE2 Melanoma (Skin Cancer) ClinicalTrials.gov
    LNS8801 BIOLOGICAL Phase PHASE2 Melanoma (Skin Cancer) ClinicalTrials.gov
    CBX-250 DRUG Phase PHASE1 High-risk Myelodysplastic Syndrome ClinicalTrials.gov
    Timolol 0.5% DRUG Phase PHASE2 Glaucoma Open-Angle Primary ClinicalTrials.gov
    H-1337 Placebo DRUG Phase PHASE2 Glaucoma Open-Angle Primary ClinicalTrials.gov
    H-1337 1.0% DRUG Phase PHASE2 Glaucoma Open-Angle Primary ClinicalTrials.gov
    H-1337 0.6% DRUG Phase PHASE2 Glaucoma Open-Angle Primary ClinicalTrials.gov
    STUP-001 DRUG Phase PHASE1 Spinal Cord Injury ClinicalTrials.gov
    Zanubrutinib DRUG Phase PHASE1 Large B-cell Lymphoma ClinicalTrials.gov
    GFH009 DRUG Phase PHASE1 Large B-cell Lymphoma ClinicalTrials.gov
    TTI-0102 DRUG Phase PHASE2 MELAS Syndrome ClinicalTrials.gov
    NST-628 DRUG Phase PHASE1 Oncology ClinicalTrials.gov
    Gem/nab-PTX DRUG Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    mFOLFIRINOX adjuvant chemotherapy DRUG Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Nal-IRI/FL DRUG Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Suizenji (an ultrasound-guided HIFU therapy system) DEVICE Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Saroglitazar Magnesium 2 mg DRUG Phase PHASE1 Hepatic Impairment ClinicalTrials.gov
    Control OTHER Approved Post-traumatic Stress Disorder ClinicalTrials.gov
    SAT014 DEVICE Approved Post-traumatic Stress Disorder ClinicalTrials.gov
    Azacitidine (AZA) DRUG Phase PHASE1 Acute Myeloid Leukaemia (AML) ClinicalTrials.gov
    Infigratinib is provided as sprinkle capsules for daily oral administration DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib or placebo comparator is provided as sprinkle capsules for daily oral administration DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    Infigratinib is provided as a single dose of minitablets for oral administration DRUG Phase PHASE2 Achondroplasia ClinicalTrials.gov
    GFH925 DRUG Phase PHASE1 Advance Non-small Cell Lung Cancer ClinicalTrials.gov
    Regorafenib (STIVARGA®, BAY73-4506) DRUG Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    IMC-001 DRUG Phase PHASE2 Extranodal NK/T-cell Lymphoma, Nasal Type ClinicalTrials.gov
    hyaluronic acid DRUG Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    Bone marrow mesenchymal stem cells DRUG Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    YA-101 DRUG Phase PHASE2 Multiple System Atrophy ClinicalTrials.gov
    Memantine DRUG Phase PHASE2 Lupus Erythematosus, Systemic ClinicalTrials.gov
    ET140203 autologous T cell product BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    RBT-1 DRUG Preclinical Post-Operative Complications in Cardiac Surgery ClinicalTrials.gov
    CLN-619 DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    KSQ-001EX DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Topical Ophthalmic Cooling DEVICE Approved Eye Pain ClinicalTrials.gov
    NPX887 DRUG Phase PHASE1 Metastatic Malignant Neoplasm ClinicalTrials.gov
    AFNT-211 DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    SNV4818 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Placebo SION-109 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    Placebo SION-2222 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    Placebo SION-451 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    SION-109 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    SION-2222 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    SION-451 DRUG Phase PHASE1 Cystic Fibrosis (CF) ClinicalTrials.gov
    ETX-19477 DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    High dose CLN-301 GENETIC Phase PHASE1 CLN3 ClinicalTrials.gov
    Low dose CLN-301 GENETIC Phase PHASE1 CLN3 ClinicalTrials.gov
    IVW-1001 Ophthalmic Eyelid Wipe DRUG Phase PHASE2 Dry Eye Disease ClinicalTrials.gov
    Clinical Learning Study smartphone app (i.e., the study app) DEVICE Approved Schizophrenia ClinicalTrials.gov
    A195/placebo DRUG Phase PHASE2 Coronary Artery Disease (CAD) ClinicalTrials.gov
    XC001 DRUG Phase PHASE2 Coronary Artery Disease (CAD) ClinicalTrials.gov
    GVB-2001-low dose DRUG Phase PHASE1 Primary Open-Angle Glaucoma (POAG) ClinicalTrials.gov
    GVB-2001-high dose DRUG Phase PHASE1 Primary Open-Angle Glaucoma (POAG) ClinicalTrials.gov
    Eflornithine (Dose Level -1) DRUG Phase PHASE1 Glioblastoma, IDH-wildtype ClinicalTrials.gov
    Eflornithine (Dose Level 2) DRUG Phase PHASE1 Glioblastoma, IDH-wildtype ClinicalTrials.gov
    Eflornithine (Dose Level 1) DRUG Phase PHASE1 Glioblastoma, IDH-wildtype ClinicalTrials.gov
    ORM-5029 DRUG Phase PHASE1 HER2-positive Breast Cancer ClinicalTrials.gov
    Saroglitazar Magnesium 4 mg DRUG Phase PHASE2 Nonalcoholic Fatty Liver Disease ClinicalTrials.gov
    Autologous DCs derived from PBMC loaded with RNA encoding the human CMV matrix protein pp65-flLAMP plus GM-CSF BIOLOGICAL Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Datopotamab deruxtecan-dlnk (Dato-DXd) DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Carboplatin AUC 6 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    SAT-003 DEVICE Approved Cancer Cachexia ClinicalTrials.gov
    EIK1004-001 (IMP1707-001) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    BOLD-100 in combination with FOLFOX Chemotherapy (Dose Escalation) DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    BOLD-100 in combination with FOLFOX Chemotherapy (Dose Expansion) DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    Osimertinib DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Nivolumab & Ipilimumab DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    VT3989 DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    LAT010 + ICI DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    LAT010 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Lenalidomide DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    ReMMi-D Digital Therapeutic DEVICE Approved Migraine ClinicalTrials.gov
    Lenalidomide 25 MG Oral Capsule DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Background Treatment DRUG Phase PHASE1 Periprosthetic Joint Infection (PJI) ClinicalTrials.gov
    Oral antibiotics DRUG Phase PHASE1 Periprosthetic Joint Infection (PJI) ClinicalTrials.gov
    Vancomycin Hydrochloride for Injection (IV) DRUG Phase PHASE1 Periprosthetic Joint Infection (PJI) ClinicalTrials.gov
    Vancomycin Hydrochloride for Injection (IA) DRUG Phase PHASE1 Periprosthetic Joint Infection (PJI) ClinicalTrials.gov
    Single vision spectacles OTHER Approved Myopia ClinicalTrials.gov
    SAT-001 DEVICE Approved Myopia ClinicalTrials.gov
    Aliya Pulsed Electric Fields (PEF) DEVICE Approved Lung Neoplasm Malignant ClinicalTrials.gov
    Allogeneic Human E-islet (E-islet 01) BIOLOGICAL Phase PHASE1 Diabetes Mellitus, Type 1 ClinicalTrials.gov
    CTO, Temodar®, Radiation therapy DRUG Phase PHASE1 Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas ClinicalTrials.gov
    CTO and Temodar® DRUG Phase PHASE1 Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas ClinicalTrials.gov
    OBX-115 BIOLOGICAL Phase PHASE1 Tumor Skin ClinicalTrials.gov
    Electrocardiography PROCEDURE Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Bone Marrow Biopsy PROCEDURE Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Bone Marrow Aspirate PROCEDURE Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Umbilical Cord Blood Transplantation PROCEDURE Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Total-Body Irradiation RADIATION Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Thiotepa DRUG Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Dilanubicel BIOLOGICAL Phase PHASE2 Acute Biphenotypic Leukemia ClinicalTrials.gov
    Bone Scan PROCEDURE Phase PHASE1 Castration-Resistant Prostate Carcinoma ClinicalTrials.gov
    Anti-STEAP1 CAR T-cells BIOLOGICAL Phase PHASE1 Castration-Resistant Prostate Carcinoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: C4 Therapeutics Inc
    • Ticker Symbol: CCCC

Search

News categories